Mimotopes is a global leader in high quality research-grade peptide products and applications for the drug discovery industry. As the innovator of peptide library production, with our unique and proprietary SynPhase™ platform and technical expertise, Mimotopes has over 18 years experience developing solid-phase synthesis technology for peptides and discovery chemistry.

Core competencies include:

• Proprietary SynPhase(TM) technology for solid phase synthesis and the capture or immobilization of biomolecules
• High throughput capabilities for the synthesis and analysis of peptides and small organic molecules
  
• Worldwide technical support leveraging on broad peptide synthesis, medicinal chemistry and organic synthesis expertise
  
• More than a decade of experience in international drug discovery research collaborations
• Global market access, directly or through distributors in key territories
• Demonstrated expertise in biological applications of chemical libraries

Genzyme Pharmaceuticals, a business unit of Genzyme Corporation, is a premier business partner in the process development, cGMP manufacturing, and regulatory support of pharmaceutical materials and APIs focusing on peptides, peptidomimetics, peptide intermediates, and peptide drug delivery. Genzyme Pharmaceuticals also offers a wide range of lipid based drug delivery technologies and products, including lipopeptides

Core competencies include:

• Process Feasibility Study and Development
• Analytical Development
• Process and Analytical Validation
• Stress and Stability Studies
• GMP Manufacture for Clinical Use and Commercialization
• Worldwide Quality Assurance and Regulatory Support